Lexicon Pharmaceuticals | LXRX - Market Capitalization

Stock Price
1.31
Daily Change
0 0%
Monthly
5.65%
Yearly
66.90%
Q1 Forecast
2.01

Lexicon Pharmaceuticals reported $322.6M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Akebia Therapeutics USD 322M 180M Jun/2025
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Coherus Biosciences USD 278M 184M Jun/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Illumina USD 21.21B 588M Feb/2026
Insmed USD 30.44B 11.35B Sep/2025
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Lexicon Pharmaceuticals USD 267M 294M Sep/2023
MacroGenics USD 114M 8M Feb/2026
MannKind USD 1.65B 511M Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
PTC Therapeutics USD 4.88B 1B Sep/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025
Vanda Pharmaceuticals USD 243M 136M Dec/2023